Use of FRIL proteins for reducing the production of pro-inflammatory cytokines

Details for Australian Patent Application No. 2006235254 (hide)

Owner Morningside Venture Investments Limited

Inventors Dinarello, Charles A.; Moore, Jeffrey G.

Agent Davies Collison Cave

Pub. Number AU-A-2006235254

PCT Pub. Number WO2006/110577

Priority 60/669418 08.04.05 US

Filing date 7 April 2006

Wipo publication date 19 October 2006

International Classifications

A61K 38/16 (2006.01) Medicinal preparations containing peptides - Peptides having more than 20 amino acids

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 37/06 (2006.01) Drugs for immunological or allergic disorders

Event Publications

29 November 2007 PCT application entered the National Phase

  PCT publication WO2006/110577 Priority application(s): WO2006/110577

11 March 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006235255-Interspinous vertebral and lumbosacral stabilization devices and methods of use

2006235251-Alkaline regeneration of NMethyl-D-glucamine functional resins